Shanghai United Imaging Healthcare (688271) Fundamentals 2026 — P/E 130.9x, Revenue Analysis | SniperIQ
Shanghai United Imaging Healthcare (688271) is a CN-listed Healthcare company in Medical - Specialties with a market capitalization of ¥93.8B, trading at ¥113.84 on the SHH. This SniperIQ fundamentals page covers Shanghai United Imaging Healthcare's valuation (P/E 130.9x, P/B 4.3x), profitability (net margin 6.4%), revenue (¥13.8B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Shanghai United Imaging Healthcare's market cap?
Shanghai United Imaging Healthcare (688271) has a market capitalization of approximately ¥93.8B, trading at ¥113.84 on the SHH. Market cap moves with the live share price.
What is Shanghai United Imaging Healthcare's P/E ratio?
Shanghai United Imaging Healthcare's trailing twelve-month P/E ratio is 130.9x, with a price-to-book (P/B) of 4.3x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Shanghai United Imaging Healthcare?
Shanghai United Imaging Healthcare runs a net profit margin of 6.4%, a gross margin of 41.3%, and an operating margin of 18.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Shanghai United Imaging Healthcare generate?
Shanghai United Imaging Healthcare reported revenue of ¥13.8B for fiscal year 2025, with net income of ¥1.9B and earnings per share (EPS) of 2.28. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Shanghai United Imaging Healthcare pay a dividend?
Shanghai United Imaging Healthcare offers a trailing dividend yield of about 0.3%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Shanghai United Imaging Healthcare financially healthy?
Shanghai United Imaging Healthcare carries a debt-to-equity ratio of 0.07x and a current ratio of 2.47x, with a market beta of 0.34. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Shanghai United Imaging Healthcare a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Shanghai United Imaging Healthcare (688271) the key facts are: market cap ¥93.8B, P/E 130.9x, revenue ¥13.8B, 52-week range 95.9-164.5. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Shanghai United Imaging Healthcare's full fundamentals live
Get Shanghai United Imaging Healthcare's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.